Author:
Abrahim Aiman,Luurtsema Gert,Bauer Martin,Karch Rudolf,Lubberink Mark,Pataraia Ekaterina,Joukhadar Christian,Kletter Kurt,Lammertsma Adriaan A.,Baumgartner Christoph,Müller Markus,Langer Oliver
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine
Reference35 articles.
1. McTavish D, Sorkin EM. Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension. Drugs 1989;38(1):19–76.
2. Eichelbaum M, Ende M, Remberg G, Schomerus M, Dengler HJ. The metabolism of DL-[14C]verapamil in man. Drug Metab Dispos 1979;7(3):145–8.
3. Pauli-Magnus C, von Richter O, Burk O, Ziegler A, Mettang T, Eichelbaum M, et al. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein. J Pharmacol Exp Ther 2000;293(2):376–82.
4. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999;39:361–98.
5. Hendrikse NH, Schinkel AH, de Vries EG, Fluks E, Van der Graaf WT, Willemsen AT, et al. Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography. Br J Pharmacol 1998;124(7):1413–8.
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献